Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.15B | 1.95B | 1.82B | 1.86B | 1.81B |
Gross Profit | 2.00B | 1.66B | 754.10M | 884.30M | 874.30M |
EBITDA | 1.19B | 992.70M | 1.18B | 1.19B | 1.16B |
Net Income | 264.70M | 126.90M | 204.90M | -56.80M | 453.40M |
Balance Sheet | |||||
Total Assets | 16.77B | 15.65B | 14.53B | 14.44B | 14.18B |
Cash, Cash Equivalents and Short-Term Investments | 1.67B | 1.40B | 340.40M | 240.90M | 744.10M |
Total Debt | 10.79B | 10.00B | 8.44B | 7.98B | 8.45B |
Total Liabilities | 14.77B | 13.60B | 12.02B | 11.48B | 11.15B |
Stockholders Equity | 2.00B | 2.06B | 2.51B | 2.96B | 3.03B |
Cash Flow | |||||
Free Cash Flow | -79.90M | -19.00M | 93.50M | 305.90M | 221.80M |
Operating Cash Flow | 918.10M | 745.10M | 787.50M | 934.40M | 865.80M |
Investing Cash Flow | -987.20M | -731.40M | -593.40M | -639.70M | -555.70M |
Financing Cash Flow | 358.80M | 1.04B | -85.00M | -809.70M | -89.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | £20.40B | 17.14 | 12.29% | 3.48% | -3.11% | -31.10% | |
71 Outperform | £53.78B | 17.58 | 8.35% | 4.31% | -7.42% | 5.84% | |
70 Outperform | £7.80B | 6.18 | -5.95% | 2.49% | -4.82% | -123.58% | |
67 Neutral | €25.64B | 16.52 | 12.01% | 5.03% | -1.81% | 134.23% | |
64 Neutral | £7.88B | 29.62 | 13.05% | 4.55% | 10.04% | ― | |
64 Neutral | £2.39B | ― | -4.44% | 6.74% | 15.42% | -406.43% | |
63 Neutral | £8.09B | 35.07 | 12.73% | 4.58% | 3.78% | 50.18% |